Relapsed/Refractory FLT3-mutated AML
1 clinical trials · Condition
◉ Watch Relapsed/Refractory FLT3-mutated AML
| Record | Firm | Date |
|---|---|---|
| A Study of Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia (NCT03324243) | Arog Pharmaceuticals, Inc. | 2018-01-01 |
Track Relapsed/Refractory FLT3-mutated AML automatically
Every clearance here is in the API, with alerts when new ones post.